Catalyst Clinical Research has merged with Ce3.
The union creates a market-leading oncology CRO solution with a particular expertise working with biotech sponsors on complex cancer therapies and study designs.
The combined entity, headquartered in Wilmington, NC, will benefit from a Northeast presence, with an office in Clinton, CT.